Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled Trial-Reference-Cited by-同舟云学术

Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled Trial

Published:1998-02 Issue:2 Volume:26 Page:346-354
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Brun‐Buisson C.,Sollet J. P.,Schweich H.,Briere S.,Petit C.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/26/2/346/1366279/26-2-346.pdf

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is There Evidence on the Optimal Duration of Aminoglycoside Therapy in β-Lactam/Aminoglycoside Combination Regimens Used for the Treatment of Gram-Negative Bacterial Infections? A Systematic Review;International Journal of Antimicrobial Agents;2024-10

2. Role of Amikacin in the management of Ventilator-associated Pneumonia;Recent Updates in Intensive Care Medicine [Working Title];2024-06-13

3. Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India;Cureus;2024-02-19

4. Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study;Annals of Intensive Care;2022-11-17

5. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial;The Lancet Infectious Diseases;2020-03